Healthcare Realty Trust Incorporated [HR] is -12.69% lower this YTD. Is it still time to buy?

Healthcare Realty Trust Incorporated [NYSE: HR] closed the trading session at $24.34 on 09/08/22. The day’s price range saw the stock hit a low of $24.10, while the highest price level was $24.58. The company report on August 9, 2022 that Healthcare Realty Trust Reports Results for the Second Quarter.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.


All Data Is Presented on a Pre-Merger Basis, Unless Otherwise Noted.

Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the second quarter ended June 30, 2022. The Company reported net income of $6.1 million, or $0.04 per diluted common share, for the quarter ended June 30, 2022. Normalized FFO for the three months ended June 30, 2022 totaled $67.0 million, or $0.45 per diluted common share. Please note that all information is presented on a pre-merger basis, unless otherwise noted.

The stocks have a year to date performance of -12.69 percent and weekly performance of 0.08 percent. The stock has been moved at -5.31 percent over the last six months. The stock has performed -5.88 percent around the most recent 30 days and changed -4.32 percent over the most recent 3-months.

If compared to the average trading volume of 7.69M shares, HR reached to a volume of 3186853 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Healthcare Realty Trust Incorporated [HR]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HR shares is $30.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HR stock is a recommendation set at 2.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

SMBC Nikko have made an estimate for Healthcare Realty Trust Incorporated shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on August 11, 2022. While these analysts kept the previous recommendation, Citigroup raised their target price to Neutral. The new note on the price target was released on August 09, 2022, representing the official price target for Healthcare Realty Trust Incorporated stock. Previously, the target price had yet another raise to $27, while JP Morgan analysts kept a Neutral rating on HR stock.

The Average True Range (ATR) for Healthcare Realty Trust Incorporated is set at 0.57, with the Price to Sales ratio for HR stock in the period of the last 12 months amounting to 13.82. The Price to Book ratio for the last quarter was 1.67, with the Price to Cash per share for the same quarter was set at 0.09. Price to Free Cash Flow for HR in the course of the last twelve months was 256.27.

HR stock trade performance evaluation

Healthcare Realty Trust Incorporated [HR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.08. With this latest performance, HR shares dropped by -5.88% in over the last four-week period, additionally sinking by -5.31% over the last 6 months – not to mention a drop of -6.47% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HR stock in for the last two-week period is set at 40.34, with the RSI for the last a single of trading hit 36.47, and the three-weeks RSI is set at 38.21 for Healthcare Realty Trust Incorporated [HR]. The present Moving Average for the last 50 days of trading for this stock 26.42, while it was recorded at 24.16 for the last single week of trading, and 30.03 for the last 200 days.

Healthcare Realty Trust Incorporated [HR]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Healthcare Realty Trust Incorporated [HR] shares currently have an operating margin of +22.30 and a Gross Margin at +28.89. Healthcare Realty Trust Incorporated’s Net Margin is presently recorded at +12.89.

Return on Equity for this stock inclined to 3.05, with Return on Assets sitting at 1.43.

Healthcare Realty Trust Incorporated [HR]: Insider Ownership positions

There are presently around $9,274 million, or 61.40% of HR stock, in the hands of institutional investors. The top three institutional holders of HR stocks are: VANGUARD GROUP INC with ownership of 54,227,546, which is approximately 1.253% of the company’s market cap and around 0.20% of the total institutional ownership; BLACKROCK INC., holding 37,388,627 shares of the stock with an approximate value of $910.04 million in HR stocks shares; and COHEN & STEERS, INC., currently with $478.19 million in HR stock with ownership of nearly -23.589% of the company’s market capitalization.

Positions in Healthcare Realty Trust Incorporated stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 229 institutional holders increased their position in Healthcare Realty Trust Incorporated [NYSE:HR] by around 61,000,884 shares. Additionally, 269 investors decreased positions by around 61,555,735 shares, while 62 investors held positions by with 258,447,631 shares. The mentioned changes placed institutional holdings at 381,004,250 shares, according to the latest SEC report filing. HR stock had 57 new institutional investments in for a total of 9,255,911 shares, while 68 institutional investors sold positions of 8,847,019 shares during the same period.


Please enter your comment!
Please enter your name here